Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: To all: I've noticed that some posters are asking

Just playing devils advocate here... I agree that the health of the company is as good right now as it has ever been (esp with positive litigation & propper M&A decision/s).. Obviously the BOD had to make the final decision on most of these.. but IMO they had a guiding hand in some of them..

No more divys.. possibly the reason divys were given initially was distribution of more cash directly to Swartz.. He certainly was the major beneficiary of the first two (& 3rd).. and since Swartz has agreed to, or decided to, get rid of all warrants and even a lrg portion of his retail, there then was no reason to give divys anymore, certainly not according to Swartz.

Warrants gone... possibly Swartz' decision.. to hedge his bet and exposure by converting/selling all/as much before potential neg litigation result, and all at the same time locking in guaranteed profits (on over 100 mil sh) of anywhere from 40 cents to $2 / sh...

New BOD member.. Tredenick.. Certainly Turly's choice. Turley new CEO from BOD

PR... couldn't have gotten any worse.. certainly better as of late

Share buyback... started under Pohl.. contniued under Turley.. very good thing... but, many here took exception with the timing of the initialization of the share buyback... and thought, correctly IMO, that the buyback should have started early in the yr last yr (18 mil shares may have been bought with $6-7mil, and WE certainly didn't know we'd see 40s again) and initiated instead of the divys that were handed out, again, mainly to Swartz... the BOD certainly agreed to that.

Anyway.. it is what it is/was.. Here's to great future BOD/CEO decisions regarding the use of settlement/MMP monies!!

regards

Share
New Message
Please login to post a reply